Identification of high risk patients with hypertrophic cardiomyopathy in a northern Greek population

Cardiovascular Ultrasound

Volumn 7, Issue 1, 2009, Pages

  Efthimiadis, Georgios K ^a   Pliakos, Christodoulos ^a   Pagourelias, Efstathios D ^a   Parcharidou, Despina G ^a   Giannakoulas, Georgios ^a   Kamperidis, Vasileios ^a   Hadjimiltiades, Stavros ^a   Karvounis, Charalambos ^a   Gavrielidis, Stavros ^a   Styliadis, Ioannis H ^a   Parcharidis, Georgios ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VERAPAMIL; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FAMILY HISTORY; FEMALE; FOLLOW UP; GREECE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; SUDDEN DEATH; SYNCOPE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 68949207989     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-7-37     Document Type: Article

References (17)

1. Hypertrophic cardiomyopathy. BJ Maron, Lancet 1997 350 127 133 10.1016/S0140-6736(97)01282-8 9228976
2. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. BJ Maron JM Gardin JM Flack SS Gidding TT Kurosaki DE Bild, Circulation 1995 92 785 789 7641357
3. Sudden death in young competitive athletes: clinical, demographic and pathological profiles. BJ Maron J Shirani LC Poliac R Mathenge WC Roberts FO Mueller, JAMA 1996 276 199 204 10.1001/jama.276.3.199 8667563
4. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. PM Elliott J Poloniecki S Dickie S Sharma L Monserrat A Varnava NG Mahon WJ McKenna, J Am Coll Cardiol 2000 36 2212 2218 10.1016/S0735-1097(00) 01003-2 11127463
5. Hypertrophic cardiomyopathy: a systematic review. BJ Maron, JAMA 2002 287 1308 1320 10.1001/jama.287.10.1308 11886323
6. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. P Spirito P Bellone KM Harris P Bernabo P Bruzzi BJ Maron, N Engl J Med 2000 342 1778 1785 10.1056/NEJM200006153422403 10853000
7. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. PM Elliott JR Gimeno NG Mahon JD Poloniecki WJ McKenna, Lancet 2001 357 420 424 10.1016/S0140-6736(00)04005-8 11273061
8. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. BJ Maron W-K Shen MS Link AE Epstein AK Almquist JP Daubert GH Bardy S Favale RF Rea G Boriani NA Estes 3rd P Spirito, N Engl J Med 2000 342 365 373 10.1056/NEJM200002103420601 10666426
9. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. I Olivotto BJ Maron A Montereggi F Mazzuoli A Dolara F Cecchi, J Am Coll Cardiol 1999 33 2044 2051 10.1016/S0735-1097(99)00094-7 10362212
10. Prospective diagnostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. N Sadoul K Prasad PM Elliott S Bannerjee MP Frenneaux WJ McKenna, Circulation 1997 96 2987 2991 9386166
11. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. F Cecchi BJ Maron SE Epstein, J Am Coll Cardiol 1989 13 1283 1288 2703610
12. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. BJ Maron RO Bonow RO Cannon 3rd MB Leon SE Epstein, N Engl J Med 1987 316 780 789 3547130
13. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. HG Klues A Schiffers BJ Maron, J Am Coll Cardiol 1995 26 1699 1708 10.1016/0735-1097(95) 00390-8 7594106
14. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. DJ Sahn A DeMaria J Kisslo A Weyman, Circulation 1978 58 1072 1083 709763
15. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. JA Panza RK Petrone L Fananapazir BJ Maron, J Am Coll Cardiol 1992 19 91 99 1729351
16. Survival following cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. PM Elliott S Sharma A Varnava J Poloniecki E Rowland WJ McKenna, J Am Coll Cardiol 1999 33 1596 1601 10.1016/S0735-1097(99)00056-X 10334430
17. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. PJ Counihan MP Frenneaux DJ Webb WJ McKenna, Circulation 1991 84 686 696 1860213